Serotype-Specific IgG Antibody Waning after Pneumococcal Conjugate Primary Series Vaccinations with either the 10-Valent or the 13-Valent Vaccine

Serotype-Specific IgG Antibody Waning after Pneumococcal Conjugate Primary Series Vaccinations with either the 10-Valent or the 13-Valent Vaccine

The two currently available ten- and thirteen-valent pneumococcal conjugate vaccines (PCV10 and PCV13) both induce serotype-specific IgG anti-polysaccharide antibodies and are effective in preventing vaccine serotype induced invasive pneumococcal disease (IPD) as well as in reducing overall vaccine-...

Full description

Bibliographic Details
Main Authors: Els van Westen, Mirjam J. Knol, Alienke J. Wijmenga-Monsuur, Irina Tcherniaeva, Leo M. Schouls, Elisabeth A. M. Sanders, Cecile A. C. M. van Els, Guy A. M. Berbers, Nynke Y. Rots
Format: Article
Language:English
Published: MDPI AG 2018-12-01
Series:Vaccines
Subjects:
pneumococcal conjugate vaccine
PCV10
PCV13
IgG
antibody kinetics
serotype-specific
Online Access:https://www.mdpi.com/2076-393X/6/4/82

Internet

https://www.mdpi.com/2076-393X/6/4/82

Similar Items